RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients
treated with chemotherapy. It is not known whether receiving dexamethasone with granisetron
is more effective than receiving dexamethasone with metoclopramide for reducing the side
effects of chemotherapy.
PURPOSE: Randomized phase III trial to compare the effectiveness of dexamethasone with either
granisetron or metoclopramide in patients treated with chemotherapy.
Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma
Unknown status
Simbec Research
Phase 3
1969-12-31
RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients
treated with radiation therapy. It is not yet known whether lerisetron is more effective than
granisetron in preventing nausea and vomiting.
PURPOSE: Randomized phase III trial to compare the effectiveness of lerisetron with that of
granisetron in preventing nausea and vomiting in men who are being treated with radiation
therapy for stage I seminoma.
Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
Unknown status
National Cancer Institute (NCI)
Phase 3
1969-12-31
RATIONALE: Antiemetic drugs such as granisetron may help to prevent nausea and vomiting in
patients treated with chemotherapy.
PURPOSE: Randomized phase III trial to compare the effectiveness of granisetron with that of
a placebo in preventing nausea and vomiting after chemotherapy in patients who have malignant
disease.
Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
Unknown status
Jonsson Comprehensive Cancer Center
Phase 3
1969-12-31
RATIONALE: Antiemetic drugs such as granisetron may help to prevent nausea and vomiting in
patients treated with chemotherapy.
PURPOSE: Randomized phase III trial to compare the effectiveness of granisetron with that of
a placebo in preventing nausea and vomiting after chemotherapy in patients who have malignant
disease.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
